Hepcvir L 400 mg/90 mg (Sofosbuvir/Ledipasvir) Global Medship or post‑inflammatory processes

or post‑inflammatory processes

Clinically established infection treatment

Alcohol consumption should be limited as it may increase side effects

Patients often ask whether 40 mg is safe and how it compares to lower Vardenafil strengths

Hypertension: It helps to lower high blood pressure

Hepcvir L 400 mg/90 mg (Sofosbuvir/Ledipasvir) Global Medship or post‑inflammatory processesProduct Overview Hepcvir L 400 mg 90 mg is a fixeddose combination tablet that contains the antiviral agents sofosbuvir and ledipasvir. Manufactured by Cipla Limited, the medication is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. Each bottle provides 28 tablets, offering a full course of therapy when used according to the recommended regimen. The product is supplied in a sealed, tamperevident bottle to maintain